新桥生物 NBP 深 沪
等待开盘 05-12 09:30:00 美东时间
2.149
-0.051
-2.32%
华盛通- 最 高2.2197
- 今 开2.18
- 成交量 36.53万股
- 最 低 2.13
- 昨 收 2.20
- 总市值 2.49亿
- 52周最高 6.79
- 市盈率 静 --
- 换手率 0.32%
- 52周最低 0.90
- 委 比 -69.59%
- 总股本 1.16亿
- 历史最高 85.40
- 量 比 0.49
- 振 幅 4.08%
- 历史最低 0.595
- 每 手 1
- 风险率 1.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alpha Buying: Insider Conviction in High-Risk Biotech
Insider buying matters in every industry, but it carries a special weight in bi...
05-08 00:04
NovaBridge Biosciences Appoints Mark Hagler As President And Chief Commercial Officer
Seasoned Biopharma leader bringing deep commercial experience to shape and inform corporate strategy, clinical trial design and business development discussionsStrong industry reputation and commercial track record in
04-22 19:11
I-Mab Biopharma GAAP EPS of -$0.48
I-Mab Biopharma press release (NBP): FY GAAP EPS of -$0.48. As of December 31, 2025, the Company had cash, cash equivalents, and short-term investments of $210.8 million. The Company’s current cash po...
04-08 05:26
NovaBridge Biosciences director Conor Chia-hung Yang files initial beneficial ownership statement
NovaBridge Biosciences director Conor Chia-hung Yang files initial beneficial ownership statement NovaBridge Biosciences director Conor Chia-hung Yang reported employee share options covering 148,623 ADSs, per an initial beneficial ownership filing dated March 18, 2026. Disclaimer: This news brief w
04-01 18:12
NovaBridge Biosciences CFO Lei Ming Kyler files initial beneficial ownership statement
NovaBridge Biosciences CFO Lei Ming Kyler files initial beneficial ownership statement NovaBridge Biosciences filed an initial statement of beneficial ownership naming Lei Ming Kyler as Chief Financial Officer. Lei Ming Kyler reported a 2025 Employee Share Option covering 996,775 ordinary shares. Th
03-19 09:40
NovaBridge Biosciences Director Fu Wei Files Initial Beneficial Ownership Statement
NovaBridge Biosciences Director Fu Wei Files Initial Beneficial Ownership Statement NovaBridge Biosciences reported an initial statement of beneficial ownership filed by Fu Wei, a director. The filing listed indirect holdings of 11,784,164 ordinary shares through CBC Investment l-Mab. It also report
03-19 09:38
NovaBridge Biosciences director Emmett Cunningham files initial beneficial ownership statement
NovaBridge Biosciences director Emmett Cunningham files initial beneficial ownership statement NovaBridge Biosciences reported that Emmett Cunningham filed an initial statement of beneficial ownership as a director. The filing disclosed a 2025 employee share option covering 120,000 shares with an ex
03-19 09:36
NovaBridge Biosciences Director Liu Xin Files Initial Beneficial Ownership Statement
NovaBridge Biosciences Director Liu Xin Files Initial Beneficial Ownership Statement NovaBridge Biosciences filed an initial statement of beneficial ownership on March 18, 2026. The filing lists Xin Liu as a director. The form states that no securities are beneficially owned by Xin Liu. Disclaimer:
03-19 09:35
NovaBridge Biosciences Director Woo Ian Ying Files Initial Beneficial Ownership Statement
NovaBridge Biosciences Director Woo Ian Ying Files Initial Beneficial Ownership Statement NovaBridge Biosciences reported that Ian Ying Woo filed an initial statement of beneficial ownership as a director, with the event date listed as 03/18/2026. The filing lists a 2025 employee share option coveri
03-19 09:31
